Corporate News     10-May-24
Glenmark Pharmaceuticals to acquire stake in a renewable power entity
Glenmark Pharmaceuticals (GPL) announced that for consumption and supply of renewable energy has entered into Securities Subscription & Shareholdersf Agreement with O2 Renewable Energy XXIV and O2 Energy SG PTE and Power Purchase Agreement with O2 Renewable Energy XXIV.

In line with GPL's commitment to become carbon neutral by 2030, this investment will enhance the share of renewable power in its operation. The acquisition of shares will enable GPL to invest in renewable energy and thereby comply with regulatory requirement for being a captive user under Indian electricity laws. GPL will acquire minimum 26% stake on fully diluted basis in O2 Renewable Energy XXIV in order to qualify for captive requirements as per the provision of Electricity Act, 2003. Post]acquisition, O2 Renewable Energy XXIV, will become an associate of GPL.

Previous News
  Glenmark Pharmaceuticals Ltd up for third straight session
 ( Hot Pursuit - 18-May-24   13:05 )
  Glenmark receives USFDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
 ( Corporate News - 17-May-24   09:05 )
  Glenmark Pharmaceuticals declare Quarterly Result
 ( Corporate News - 15-May-24   12:59 )
  Glenmark Pharmaceuticals to acquire stake in a renewable power entity
 ( Corporate News - 10-May-24   17:45 )
  Glenmark receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC)
 ( Corporate News - 29-Apr-24   09:47 )
  Glenmark Pharmaceuticals Ltd up for five straight sessions
 ( Hot Pursuit - 05-Apr-24   13:00 )
  Glenmark Pharmaceuticals directors resign
 ( Corporate News - 01-Apr-24   09:24 )
  Glenmark Pharmaceuticals Ltd spurts 0.28%, gains for five straight sessions
 ( Hot Pursuit - 27-Mar-24   13:00 )
  Glenmark Pharmaceuticals Ltd gains for third straight session
 ( Hot Pursuit - 11-Mar-24   13:05 )
  Glenmark Pharma reports net loss of Rs 331 cr in Q3 FY24
 ( Hot Pursuit - 15-Feb-24   11:16 )
  Glenmark Pharmaceuticals reports consolidated net loss of Rs 351.37 crore in the December 2023 quarter
 ( Results - Announcements 15-Feb-24   07:39 )
Other Stories
  Spectrum Foods to convene board meeting
  20-May-24   19:31
  Associated Ceramics to table results
  20-May-24   19:30
  Maris Spinners to convene board meeting
  20-May-24   19:30
  PTC Industries to conduct board meeting
  20-May-24   19:30
  Panth Infinity to announce Quarterly Result
  20-May-24   19:30
  GTN Industries to convene board meeting
  20-May-24   19:22
  Ganon Products announces board meeting date
  20-May-24   19:21
  Kilitch Drugs (India) to declare Quarterly Result
  20-May-24   19:21
  Inani Marbles & Industries schedules board meeting
  20-May-24   19:21
  Neeraj Paper Marketing to declare Quarterly Result
  20-May-24   19:21
Back Top